Effectiveness and safety of a mixture of diosmin, coumarin and arbutin (Linfadren®) in addition to conventional treatment in the management of patients with post-trauma/surgery persistent hand edema: a randomized controlled trial
- PMID: 30757911
- DOI: 10.1177/0269215519829797
Effectiveness and safety of a mixture of diosmin, coumarin and arbutin (Linfadren®) in addition to conventional treatment in the management of patients with post-trauma/surgery persistent hand edema: a randomized controlled trial
Abstract
Objective: To evaluate the effectiveness and safety of oral administration of Linfadren® in addition to conventional treatment in patients with post-trauma/surgery persistent hand edema.
Design: Parallel-group randomized controlled trial.
Setting: Outpatient rehabilitation center.
Subjects: A total of 60 outpatients (mean age 48.5 (standard deviation (SD) = 12.3) years) with post-trauma/surgery persistent hand edema.
Interventions: Patients were randomized to either receive six-week conventional treatment plus Linfadren® (Study Group) or conventional treatment (Control Group).
Main measures: Primary outcome was hand edema as measured by figure-of-eight method. Secondary outcomes were hand function, patient's overall perceived treatment effectiveness and rescue medication request. Tolerability of Linfadren® was also evaluated. Assessments were performed at baseline, at the end of treatment and three months after the end of treatment.
Results: All patients completed the six-week program and 57 patients (95%) completed the three-month follow-up. At six weeks, the Study Group had significantly greater improvement in hand edema (423.3 (SD = 23.8) mm vs 439.4 (SD = 22.6) mm; P = 0.009) and upper limb function ( Quick Disabilities of Arm, Shoulder and Hand questionnaire: 23.6 (SD = 13.6) vs 37.7 (SD = 15.9); P = 0.005) compared to the Control Group. Moreover, the percentage of patients who perceived treatment as effective was significantly higher in the Study Group than in the Control Group both after treatment (70% vs 37%, P = 0.002) and at follow-up (77% vs 30%, P < 0.0001). The rescue medication request was not different between groups. No adverse events were recorded.
Conclusion: Linfadren® in addition to conventional treatment was safe and more effective than conventional treatment alone in patients with post-trauma/surgery persistent hand edema.
Keywords: Edema; benzopyrones; coumarin; diosmin; forearm; hand; rehabilitation; surgery; trauma.
Similar articles
-
Effectiveness and safety of a product containing diosmin, coumarin, and arbutin (Linfadren®) in addition to complex decongestive therapy on management of breast cancer-related lymphedema.Support Care Cancer. 2019 Apr;27(4):1471-1480. doi: 10.1007/s00520-018-4514-5. Epub 2018 Oct 20. Support Care Cancer. 2019. PMID: 30343411 Clinical Trial.
-
Efficacy and Safety of the Phytochemical Product Linfadren in the Management of Patients With Persistent Ankle Edema Following Trauma or Surgery: A Randomized Controlled Trial.Foot Ankle Int. 2023 Oct;44(10):972-982. doi: 10.1177/10711007231189679. Epub 2023 Sep 19. Foot Ankle Int. 2023. PMID: 37724868 Clinical Trial.
-
Effect of mirror therapy on hand function in patients with hand orthopaedic injuries: a randomized controlled trial.Disabil Rehabil. 2013 Sep;35(19):1647-51. doi: 10.3109/09638288.2012.751132. Epub 2013 Jan 22. Disabil Rehabil. 2013. PMID: 23336124 Clinical Trial.
-
Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial.Tech Coloproctol. 2015 Jun;19(6):339-45. doi: 10.1007/s10151-015-1302-9. Epub 2015 Apr 19. Tech Coloproctol. 2015. PMID: 25893991 Clinical Trial.
-
The Effectiveness of Fluidotherapy in Poststroke Complex Regional Pain Syndrome: A Randomized Controlled Study.J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1578-1585. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.002. Epub 2019 Mar 30. J Stroke Cerebrovasc Dis. 2019. PMID: 30940426 Clinical Trial.
Cited by
-
Hepatoprotective effects of diosmin: a narrative review.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):279-295. doi: 10.1007/s00210-024-03297-z. Epub 2024 Aug 21. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39167171 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical